Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy" reports on the integration of deep learning and generative AI in radiopharmaceutical medicine, its impact on ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage ...
A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...
What are the benefits and challenges of using multiomics approaches to discover cancer biomarkers? Multiomics means that scientists are measuring more than one class of analyte, such as DNA, RNA, or ...
Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results